Astellas: Every Angle Simplifies Validation for Pharma

Description

Patrick Spit, Supply Chain Engineer at Astellas Pharma, explains that validation of reports in the pharmaceutical industry is of utmost importance because the lives of people are involved. With Every Angle, reports, that formerly took 8-10 weeks to create, can be done on-the-fly and are validated upon creation.

“If you install Every Angle, you only have to validate once, because you validate the interface and all the logistics are available. We don’t need to validate every individual report again,” explains Patrick. He then elaborates on the impact this has on shortening the time to market and how Every Angle supports Astellas in maximizing agility.

Referring to the solution in the IT landscape Spit notes that “Every Angle fits very well into the SAP landscape because there is already a certified interface, so you don’t need to develop an interface yourself. It’s certified. You can implement it within a few days.”

Highlighting how Every Angle differs from SAP BW, Spit explains “when we create a report, we don’t do it immediately in SAP BW, we first do it in Every Angle. We specify what we want, test with it, use if for some time in practice, and if it is to our satisfaction we will convert it.” He continues that, “normally when you have to create a SAP BW report, you have to specify it up-front. Most of the time, users don’t know yet, what they want. With Every Angle you can play around.”

About Astellas

Astellas is one of the top 20 pharmaceutical companies in the world, employing 17,000 people globally. As a young and forward-thinking company, Astellas is dedicated to improving the lives of people around the world through the introduction of innovative and reliable pharmaceutical products focused mainly on urology, transplantations and oncology. Astellas continues to develop first-in-class and best-in-class products in key therapeutic areas by combining outstanding R&D with marketing capabilities and continuing growth in the world pharmaceutical market. 

Astellas aims to strengthen its capabilities as a research-driven pharmaceutical company, playing the vital role of bringing innovative therapies within reach of patients around the world and continuing to build trusted networks amongst physicians and partners.